{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:45:43Z","timestamp":1772196343081,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1067\/mhj.2001.119128","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T22:14:26Z","timestamp":1030227266000},"page":"790-798","source":"Crossref","is-referenced-by-count":41,"title":["Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab"],"prefix":"10.1067","volume":"142","author":[{"given":"Mark I.","family":"Furman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean J.","family":"Kereiakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori A.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele N.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy L.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha L.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R.","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"A.L.","family":"Frelinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2001.119128_bib1","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0735-1097(00)00648-3","article-title":"Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?","volume":"35","author":"Kaul","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.119128_bib2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","article-title":"Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes","volume":"284","author":"Bhatt","year":"2000","journal-title":"JAMA"},{"key":"10.1067\/mhj.2001.119128_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI109661","article-title":"Effect of heparin and heparin fractions on platelet aggregation","volume":"65","author":"Salzman","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1067\/mhj.2001.119128_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1055\/s-0038-1648988","article-title":"Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis \u201cin vivo.\u201d","volume":"72","author":"Landolfi","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2001.119128_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/euhj.1998.1047","article-title":"Increased platelet responsiveness following coronary stenting: heparin as a possible aetiological factor in stent thrombosis","volume":"19","author":"Knight","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2001.119128_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.97.3.251","article-title":"Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor","volume":"97","author":"Xiao","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.119128_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.88.1.37","article-title":"Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA","volume":"88","author":"Tschoepe","year":"1993","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.119128_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0735-1097(95)00433-5","article-title":"Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting","volume":"27","author":"Neumann","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.119128_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00019501-199703000-00001","article-title":"Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis","volume":"8","author":"Gawaz","year":"1997","journal-title":"Coron Artery Dis"},{"key":"10.1067\/mhj.2001.119128_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0735-1097(00)00554-4","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade in coronary artery disease","volume":"35","author":"Lincoff","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.119128_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","author":"Frisc II Investigators","year":"1999","journal-title":"Lancet"},{"issue":"A Suppl","key":"10.1067\/mhj.2001.119128_bib12","first-page":"1A","article-title":"Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: \u201cNICE guys finish first.\u201d","volume":"12","author":"Kereiakes","year":"2000","journal-title":"J Invasive Cardiol"},{"key":"10.1067\/mhj.2001.119128_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina: a classification","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.119128_bib14","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","author":"EPILOG Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.119128_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein- IIb\/IIIa blockade: Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting","volume":"352","author":"EPISTENT Investigators","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.119128_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1067\/mhj.2001.113217","article-title":"Dalteparin in combination with abciximab during percutaneous coronary intervention","volume":"141","author":"Kereiakes","year":"2001","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2001.119128_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) Trial\u2014phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.119128_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.119128_bib19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","article-title":"Platelet hyperactivity and prognosis in survivors of myocardial infarction","volume":"322","author":"Trip","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.119128_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.119128_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0735-1097(97)00510-X","article-title":"Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease","volume":"31","author":"Furman","year":"1998","journal-title":"J Am Coll Cardiol."},{"key":"10.1067\/mhj.2001.119128_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.119128_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0735-1097(96)00164-7","article-title":"Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?","volume":"28","author":"Mickelson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.119128_bib24","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.CIR.94.6.1239","article-title":"Increased neutrophil-platelet adhesion in patients with unstable angina","volume":"94","author":"Ott","year":"1996","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.119128_bib25","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/01.CIR.95.10.2387","article-title":"Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets","volume":"95","author":"Neumann","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.119128_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/hrt.76.2.166","article-title":"Changes in membrane glycoproteins of circulating platelets after coronary stent implantation","volume":"76","author":"Gawaz","year":"1996","journal-title":"Heart"},{"key":"10.1067\/mhj.2001.119128_bib27","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0735-1097(97)00073-9","article-title":"Antiplatelet effect of ticlopidine after coronary stenting","volume":"29","author":"Neumann","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.119128_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1055\/s-0037-1614590","article-title":"Free and total platelet glycoprotein IIb\/IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA","volume":"81","author":"Hezard","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2001.119128_bib29","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood.V93.5.1622","article-title":"Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab fragments (abciximab): flow and endocytic mechanisms contribute to the transport","volume":"93","author":"Nurden","year":"1999","journal-title":"Blood"},{"key":"10.1067\/mhj.2001.119128_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0735-1097(95)00563-3","article-title":"Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty","volume":"27","author":"Neumann","year":"1996","journal-title":"J Am Coll Cardiol."},{"key":"10.1067\/mhj.2001.119128_bib31","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1055\/s-0037-1615400","article-title":"Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement","volume":"80","author":"Gawaz","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2001.119128_bib32","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1182\/blood.V92.9.3240","article-title":"Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb\/IIIa (alphaIIbbeta3) inhibitors","volume":"92","author":"Peter","year":"1998","journal-title":"Blood"},{"key":"10.1067\/mhj.2001.119128_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/hc3701.095950","article-title":"Dissociation of GPIIb-IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation","author":"Frelinger","year":"2001","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.119128_bib34","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1073\/pnas.93.21.11877","article-title":"In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function","volume":"93","author":"Michelson","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mhj.2001.119128_bib35","first-page":"I610","article-title":"Cathepsin G proteolyses platelet surface P-selectin and disaggregates leukocyte-platelet aggregates: mechanism for the loss of surface P-selectin from circulating degranulated platelets [abstract]","volume":"100","author":"Garnette","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.119128_bib36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1084\/jem.183.3.1193","article-title":"Interactions of human alpha\/beta and gamma\/delta T lymphocyte subsets in shear flow with E-selectin and P-selectin","volume":"183","author":"Diacovo","year":"1996","journal-title":"J Exp Med"},{"key":"10.1067\/mhj.2001.119128_bib37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood.V89.4.1270","article-title":"Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model","volume":"89","author":"Kirchhofer","year":"1997","journal-title":"Blood"},{"key":"10.1067\/mhj.2001.119128_bib38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-0037-1615912","article-title":"P-selectin\u2013beta 2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage","volume":"82","author":"Cerletti","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2001.119128_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0092-8674(89)90292-4","article-title":"PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes","volume":"59","author":"Larsen","year":"1989","journal-title":"Cell"},{"key":"10.1067\/mhj.2001.119128_bib40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/359848a0","article-title":"Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platetets","volume":"359","author":"Palabrica","year":"1992","journal-title":"Nature"},{"key":"10.1067\/mhj.2001.119128_bib41","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1073\/pnas.91.19.8767","article-title":"P-selectin induces the expression of tissue factor on monocytes","volume":"91","author":"Celi","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mhj.2001.119128_bib42","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI118575","article-title":"Activated platelets signal chemokine synthesis by human monocytes","volume":"97","author":"Weyrich","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1067\/mhj.2001.119128_bib43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0038-1642680","article-title":"Platelet activation by polymorphonuclear leukocytes: role of cathepsin G and P-selectin","volume":"74","author":"Cerletti","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2001.119128_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood.V84.1.158.158","article-title":"Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP) Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIba and by a cytoskeletal-mediated redistribution of the remainder of the complex","volume":"84","author":"LaRosa","year":"1994","journal-title":"Blood"},{"key":"10.1067\/mhj.2001.119128_bib45","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.1074\/jbc.270.19.11168","article-title":"Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G","volume":"270","author":"Molino","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1067\/mhj.2001.119128_bib46","first-page":"69","article-title":"Cathepsin G\u2013induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes?","volume":"122","author":"Pintucci","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1067\/mhj.2001.119128_bib47","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/01.CIR.98.13.1322","article-title":"Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins","volume":"98","author":"Lefer","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.119128_bib48","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/oxfordjournals.eurheartj.a015200","article-title":"Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation","volume":"18","author":"May","year":"1997","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301972941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301972941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T01:50:16Z","timestamp":1576461016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870301972941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0002870301972941"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2001.119128","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}